Altitude sickness can occur in some people as low as 8,000 feet, but serious symptoms do not usually occur until over 12,000 feet. Even then it is not the height that is important, rather the speed in which you ascended to that altitude.
Acute mountain sickness (AMS) is actually more common in fit young men because they are more likely to attempt a rapid ascent by racing up the mountain. As a general rule, it is far safer (and more enjoyable) to avoid altitude sickness by planning a sensible itinerary that allows for gradual acclimatisation to altitude as you ascend, (you can race back down as fast as you like!).
Remember ‘Go slow if you want to go fast’
|High||2,500m to 4,000 metres||8,000 to 13,000 feet|
|Very High||4,000 to 5,500 meters||13,000 to 18,000 feet|
|Extremely High||Over 5,500 meters||Over 18,000 feet|
It is difficult to determine who may be affected by altitude sickness since there are no specific factors such as age, sex, or physical condition that correlate with susceptibility. Some people get it and some people don’t because some people are more susceptible than others.
Most people can ascend to 2,500 metres (8,000 feet) with little or no effect. If you have been at that altitude before with no problem, you can probably return to that altitude without problems as long as you are properly acclimatised. If you haven’t been to high altitude before, you should exercise caution when doing so.
The percentage of oxygen in the atmosphere at sea level is about 21% and the barometric pressure is around 760 mmHg. As altitude increases, the percentage remains the same but the number of oxygen molecules per breath is reduced. At 3,600 metres (12,000 feet) the barometric pressure is only about 480 mmHg, so there are roughly 40% fewer oxygen molecules per breath so the body must adjust to having less oxygen.
In addition, high altitude and lower air pressure causes fluid to leak from the capillaries in both the lungs and the brain which can lead to fluid build-up. Continuing on to higher altitude without proper acclimatisation can lead to the potentially serious, even life-threatening altitude sickness.
The main cause of altitude sickness is going too high too quickly. Given enough time, your body will adapt to the decrease in oxygen at a specific altitude. This process is known as acclimatisation and generally takes one to three days at any given altitude, e.g. if you climb to 3,000 metres and spend several days at that altitude, your body will acclimatise to 3,000 metres. If you then climb to 5,000 metres your body has to acclimatise once again.
Several changes take place in the body which enable it to cope with decreased oxygen:
The depth of respiration increases.
The body produces more red blood cells to carry oxygen.
Pressure in pulmonary capillaries is increased, “forcing” blood into parts of the lung which are not normally used when breathing at sea level.
The body produces more of a particular enzyme that causes the release of oxygen from haemoglobin to the body tissues.
Please Note: There is NO substitute for proper acclimatisation!!
Climb High’s itinerary is planned with a high degree of awareness of AMS (Acute Mountain Sickness). So, for a safe trek, it is absolutely essential to allow sufficient time for acclimatization. Proper and sensible planning is therefore required to minimize the risk of AMS.
Above 3,000 metres (10,000 feet) most people experience a periodic breathing during sleep known as Cheyne-Stokes Respirations. The pattern begins with a few shallow breaths and increases to deep sighing respirations then falls off rapidly even ceasing entirely for a few seconds and then the shallow breaths begin again.
During the period when breathing stops the person often becomes restless and may wake with a sudden feeling of suffocation. This can disturb sleeping patterns, exhausting the climber.
This type of breathing is not considered abnormal at high altitudes. Acetazolamide (Diamox) is helpful in relieving this periodic breathing.
AMS is very common at high altitude. At over 3,000 metres (10,000 feet) 75% of people will have mild symptoms. The occurrence of AMS is dependent upon the elevation, the rate of ascent, and individual susceptibility. Many people will experience mild AMS during the acclimatisation process. The symptoms usually start 12 to 24 hours after arrival at altitude and begin to decrease in severity around the third day.
Symptoms tend to be worse at night and when respiratory drive is decreased. Mild AMS does not interfere with normal activity and symptoms generally subside within two to four days as the body acclimatises. As long as symptoms are mild, and only a nuisance, ascent can continue at a moderate rate. When hiking, it is essential that you communicate any symptoms of illness immediately to others on your trip.
The signs and symptoms of Moderate AMS include:-
Normal activity is difficult, although the person may still be able to walk on their own. At this stage, only advanced medications or descent can reverse the problem. Descending only 300 metres (1,000 feet) will result in some improvement, and twenty four hours at the lower altitude will result in a significant improvement. The person should remain at lower altitude until all the symptoms have subsided (up to 3 days). At this point, the person has become acclimatised to that altitude and can begin ascending again.
The best test for moderate AMS is to have the person walk a straight line heel to toe just like a sobriety test. A person with ataxia would be unable to walk a straight line. This is a clear indication that an immediate descent is required. It is important to get the person to descend before the ataxia reaches the point where they cannot walk on their own (which would necessitate a stretcher evacuation).
Severe AMS results in an increase in the severity of the aforementioned symptoms including: Shortness of breath at rest, Inability to walk, Decreasing mental status, Fluid build-up in the lungs. Severe AMS requires immediate descent of around 600 metres (2,000 feet) to a lower altitude.
There are two serious conditions associated with severe altitude sickness;
High Altitude Cerebral Oedema (HACO) and High Altitude Pulmonary Oedema (HAPO).
Both of these happen less frequently, especially to those who are properly acclimatised. But, when they do occur, it is usually in people going too high too fast or going very high and staying there. In both cases the lack of oxygen results in leakage of fluid through the capillary walls into either the lungs or the brain.
HAPE results from fluid build up in the lungs. This fluid prevents effective oxygen exchange. As the condition becomes more severe, the level of oxygen in the bloodstream decreases, which leads to cyanosis, impaired cerebral function, and death.
Symptoms of HAPE include:-
Confusion and irrational behaviour are signs that insufficient oxygen is reaching the brain. One of the methods for testing yourself for HAPE is to check your recovery time after exertion.
In cases of HAPE, immediate descent of around 600 metres (2,000 feet) is a necessary life-saving measure. Anyone suffering from HAPE must also be evacuated to a medical facility for proper follow-up treatment.
It generally occurs after a week or more at high altitude. Severe instances can lead to death if not treated quickly. Immediate descent of around 600 metres (2,000 feet) is a necessary lifesaving measure. There are some medications that may be used for treatment in the field, but these require proper training in their use.
Anyone suffering from HACE must be evacuated to a medical facility for follow-up treatment.
This involves proper acclimatisation and the possible use of medications.
Some basic guidelines for the prevention of AMS:-
Remember: Acclimatisation is inhibited by overexertion, dehydration, and alcohol.
This is the most tried and tested drug for altitude sickness prevention and treatment. Unlike dexamethasone (below) this drug does not mask the symptoms but actually treats the problem. It seems to works by increasing the amount of alkali (bicarbonate) excreted in the urine, making the blood more acidic. Acidifying the blood drives the ventilation, which is the cornerstone of acclimatisation.
For prevention, 125 to 250mg twice daily starting one or two days before and continuing for three days once the highest altitude is reached, is effective. Blood concentrations of acetazolamide peak between one to four hours after administration of the tablets.
Studies have shown that prophylactic administration of acetazolamide at a dose of 250mg every eight to twelve hours before and during rapid ascent to altitude results in fewer and/or less severe symptoms (such as headache, nausea, shortness of breath, dizziness, drowsiness, and fatigue) of acute mountain sickness (AMS). Pulmonary function is greater both in subjects with mild AMS and asymptomatic subjects. The treated climbers also had less difficulty in sleeping.
Gradual ascent is always desirable to try to avoid acute mountain sickness but if rapid ascent is undertaken and actazolamide is used, it should be noted that such use does not obviate the need for a prompt descent if severe forms of high altitude sickness occur, i.e. pulmonary or cerebral oedema.
Side effects of acetazolamide include: an uncomfortable tingling of the fingers, toes and face carbonated drinks tasting flat; excessive urination; and rarely, blurring of vision.
On most treks, gradual ascent is possible and prophylaxis tends to be discouraged. Certainly if trekkers do develop headache and nausea or the other symptoms of AMS, then treatment with acetazolamide is fine. The treatment dosage is 250 mg twice a day for about three days. A trial course is recommended before going to a remote location where a severe allergic reaction could prove difficult to treat if it occurred. Dexamethasone (a steroid) is a drug that decreases brain and other swelling reversing the effects of AMS. The dose is typically 4 mg twice a day for a few days starting with the ascent. This prevents most of the symptoms of altitude illness from developing.
Dexamethasone is a powerful drug and should be used with caution and only on the advice of a physician and should only be used to aid acclimatisation by sufficiently qualified persons or those with the necessary experience of its use.
The only cure for mountain sickness is either acclimatisation or descent.
Symptoms of Mild AMS can be treated with pain killers for headache, acetazolamide and dexamethasone. These help to reduce the severity of the symptoms, but remember, reducing the symptoms is not curing the problem and could even exacerbate the problem by masking other symptoms.
Acetazolamide allows you to breathe faster so that you metabolise more oxygen, thereby minimising the symptoms caused by poor oxygenation which is especially helpful at night when the respiratory drive is decreased.
Dexamethasone: This powerful steroid drug can be life saving in people with HACO, and works by decreasing swelling and reducing the pressure in the skull. The dosage is 4 mg three times per day, and obvious improvement usually occurs within about six hours. This drug “buys time” especially at night when it may be problematic to descend. Descent should be carried out the next day. It is unwise to ascend while taking dexamethasone: unlike diamox this drug only masks the symptoms.
Dexamethasone can be highly effective: many people who are lethargic or even in coma will improve significantly after tablets or an injection, and may even be able to descend with assistance.
Mountain climbers also sometimes carry this drug to prevent or treat AMS. It needs to be used cautiously, because it can cause stomach irritation, euphoria or depression.
It may be a good idea to pack this drug for a high altitude trek for emergency usage in the event of HACO In people allergic to sulpha drugs (and therefore unable to take diamox) dexamethasone can also be used for prevention: 4 mg twice a day for about three days may be sufficient.
Ibuprofen which is effective in relieving symptoms & altitude induced headache.
Nifedipine: This drug is usually used to treat high blood pressure. It rapidly decreases pulmonary artery pressure and also seems able to decrease the narrowing in the pulmonary artery caused by low oxygen levels, thereby improving oxygen transfer. It can therefore be used to treat HAPO, though unfortunately its effectiveness is not anywhere as dramatic that of dexamethasone in HACO. The dosage is 20mg of long acting nifedipine, six to eight hourly.
Nifedipine can cause a sudden lowering of blood pressure so the patient has to be warned to get up slowly from a sitting or reclining position. It has also been used in the same dosage to prevent HAPO in people with a past history of this disease.
Frusemide may clear the lungs of water in HAPO and reverse the suppression of urine brought on by altitude. However, Frusemide can also lead to collapse from low volume shock if the victim is already dehydrated. Treatment dosage is 120mg daily.
Breathing · 100% Oxygen also reduces the effects of altitude sickness.